Alex Kentsis

7.7k total citations
103 papers, 4.6k citations indexed

About

Alex Kentsis is a scholar working on Molecular Biology, Hematology and Spectroscopy. According to data from OpenAlex, Alex Kentsis has authored 103 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 22 papers in Hematology and 19 papers in Spectroscopy. Recurrent topics in Alex Kentsis's work include Acute Myeloid Leukemia Research (19 papers), Mass Spectrometry Techniques and Applications (17 papers) and Advanced Proteomics Techniques and Applications (12 papers). Alex Kentsis is often cited by papers focused on Acute Myeloid Leukemia Research (19 papers), Mass Spectrometry Techniques and Applications (17 papers) and Advanced Proteomics Techniques and Applications (12 papers). Alex Kentsis collaborates with scholars based in United States, Japan and Germany. Alex Kentsis's co-authors include Katherine L. B. Borden, Tobin R. Sosnick, Zhen‐Qiang Pan, Paolo Cifani, Ivan Topisirović, Kenneth Wu, Kosj Yamoah, Ling Shao, Biljana Čuljković and Hanno Steen and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Alex Kentsis

98 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alex Kentsis United States 37 3.4k 799 561 503 425 103 4.6k
Johannes W.G. Janssen Germany 34 1.9k 0.6× 688 0.9× 827 1.5× 577 1.1× 314 0.7× 87 4.1k
Yusuke Okuno Japan 30 1.5k 0.4× 494 0.6× 409 0.7× 505 1.0× 199 0.5× 168 3.1k
Virgil L. Woods United States 50 3.7k 1.1× 351 0.4× 451 0.8× 542 1.1× 797 1.9× 121 6.5k
Oded Kleifeld Israel 31 2.6k 0.8× 1.3k 1.6× 203 0.4× 368 0.7× 430 1.0× 79 4.3k
Peter O. Krutzik United States 26 3.5k 1.0× 1.1k 1.3× 477 0.9× 2.1k 4.2× 411 1.0× 35 6.1k
Vladimir N. Podust United States 43 4.0k 1.2× 1.1k 1.4× 369 0.7× 301 0.6× 377 0.9× 73 5.6k
Paul A. Clarke United Kingdom 46 5.1k 1.5× 2.6k 3.3× 279 0.5× 746 1.5× 379 0.9× 139 8.4k
Thomas E. Smithgall United States 52 4.3k 1.3× 1.9k 2.4× 1.1k 1.9× 1.5k 2.9× 250 0.6× 175 7.7k
Bent Honoré Denmark 39 3.4k 1.0× 697 0.9× 126 0.2× 1.0k 2.0× 559 1.3× 186 5.5k
Sander R. Piersma Netherlands 40 2.8k 0.8× 687 0.9× 167 0.3× 270 0.5× 1.1k 2.7× 137 4.7k

Countries citing papers authored by Alex Kentsis

Since Specialization
Citations

This map shows the geographic impact of Alex Kentsis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Kentsis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Kentsis more than expected).

Fields of papers citing papers by Alex Kentsis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex Kentsis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Kentsis. The network helps show where Alex Kentsis may publish in the future.

Co-authorship network of co-authors of Alex Kentsis

This figure shows the co-authorship network connecting the top 25 collaborators of Alex Kentsis. A scholar is included among the top collaborators of Alex Kentsis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Kentsis. Alex Kentsis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cameron, Daniel, Nadia Zaffaroni, Noemi Arrighetti, et al.. (2025). Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomas. Journal of Clinical Investigation. 135(20).
2.
Czaplinski, Jeffrey T., Suzanne J. Forrest, Neerav Shukla, et al.. (2024). TAZNI: A phase I/II combination trial of tazemetostat with nivolumab and ipilimumab for children with INI1-negative or SMARCA4-deficient tumors.. Journal of Clinical Oncology. 42(16_suppl). TPS10077–TPS10077.
3.
Kentsis, Alex. (2024). Toward a Unified Theory of Why Young People Develop Cancer. Cold Spring Harbor Perspectives in Medicine. 14(10). a041658–a041658.
4.
Zaffaroni, Nadia, Noemi Arrighetti, Valentina Zuco, et al.. (2024). Overcoming Clinical Resistance to EZH2 Inhibition Using Rational Epigenetic Combination Therapy. Cancer Discovery. 14(6). 965–981. 16 indexed citations
5.
Booth, Christopher A.G., Juliette Bouyssou, Katsuhiro Togami, et al.. (2024). BPDCN MYB fusions regulate cell cycle genes, impair differentiation, and induce myeloid–dendritic cell leukemia. JCI Insight. 9(24). 3 indexed citations
6.
Fan, Yujie, Celine Everaert, Wouter Van Loocke, et al.. (2023). Human iPSC modeling recapitulates in vivo sympathoadrenal development and reveals an aberrant developmental subpopulation in familial neuroblastoma. iScience. 27(1). 108096–108096. 2 indexed citations
7.
Dao, Tao, Guangyan Xiong, Tatyana Korontsvit, et al.. (2023). A dual-receptor T-cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AML. Blood. 143(6). 507–521. 18 indexed citations
8.
Yu, You, Shibai Li, Zheng Ser, et al.. (2021). Integrative analysis reveals unique structural and functional features of the Smc5/6 complex. Proceedings of the National Academy of Sciences. 118(19). 35 indexed citations
9.
Takao, Sumiko, Lauren Forbes, Shuyuan Cheng, et al.. (2021). Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia. eLife. 10. 34 indexed citations
10.
Smeenk, Leonie, Roger Mulet‐Lazaro, Anja Ebert, et al.. (2021). Selective Requirement of MYB for Oncogenic Hyperactivation of a Translocated Enhancer in Leukemia. Cancer Discovery. 11(11). 2868–2883. 29 indexed citations
11.
Gutiérrez, Alejandro & Alex Kentsis. (2018). Acute myeloid/T‐lymphoblastic leukaemia ( AMTL ): a distinct category of acute leukaemias with common pathogenesis in need of improved therapy. British Journal of Haematology. 180(6). 919–924. 19 indexed citations
12.
Henssen, Anton G., Casie Reed, Heathcliff Dorado García, et al.. (2017). Therapeutic targeting of PGBD5-induced DNA repair dependency in pediatric solid tumors. Science Translational Medicine. 9(414). 30 indexed citations
13.
Brown, Fiona C., Paolo Cifani, Esther Drill, et al.. (2016). Genomics of primary chemoresistance and remission induction failure in paediatric and adult acute myeloid leukaemia. British Journal of Haematology. 176(1). 86–91. 21 indexed citations
14.
Mathias, Melissa, Alexander J. Chou, Paul A. Meyers, et al.. (2016). Osteosarcoma With Apparent Ewing Sarcoma Gene Rearrangement. Journal of Pediatric Hematology/Oncology. 38(5). e166–e168. 2 indexed citations
15.
Laszlo, George S., Todd A. Alonzo, Chelsea J. Gudgeon, et al.. (2015). High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group. Journal of Hematology & Oncology. 8(1). 115–115. 41 indexed citations
16.
Kentsis, Alex, Laurent Volpon, Ivan Topisirović, et al.. (2005). Further evidence that ribavirin interacts with eIF4E. RNA. 11(12). 1762–1766. 81 indexed citations
17.
Topisirović, Ivan, et al.. (2005). Eukaryotic Translation Initiation Factor 4E Activity Is Modulated by HOXA9 at Multiple Levels. Molecular and Cellular Biology. 25(3). 1100–1112. 80 indexed citations
18.
Miller, Felicia M., Alex Kentsis, Roman Osman, & Zhen‐Qiang Pan. (2004). Inactivation of VHL by Tumorigenic Mutations That Disrupt Dynamic Coupling of the pVHL·Hypoxia-inducible Transcription Factor-1α Complex. Journal of Biological Chemistry. 280(9). 7985–7996. 37 indexed citations
19.
Kentsis, Alex, Ivan Topisirović, Biljana Čuljković, Ling Shao, & Katherine L. B. Borden. (2004). Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap. Proceedings of the National Academy of Sciences. 101(52). 18105–18110. 248 indexed citations
20.
Sosnick, Tobin R., et al.. (2000). D/H amide kinetic isotope effects reveal when hydrogen bonds form during protein folding.. Nature Structural Biology. 7(1). 62–71. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johannes W.G. Janssen Breakdown of academic impact, for papers by Yusuke Okuno Breakdown of academic impact, for papers by Virgil L. Woods Breakdown of academic impact, for papers by Oded Kleifeld Breakdown of academic impact, for papers by Peter O. Krutzik Breakdown of academic impact, for papers by Vladimir N. Podust Breakdown of academic impact, for papers by Paul A. Clarke Breakdown of academic impact, for papers by Thomas E. Smithgall Breakdown of academic impact, for papers by Bent Honoré Breakdown of academic impact, for papers by Sander R. Piersma
Rankless by CCL
2026